Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.
about
Radiotherapy for Colorectal Cancer: Current Standards and Future PerspectivesTreatment of colorectal cancer in the elderlyNeoadjuvant chemoradiation therapy and pathological complete response in rectal cancerInnovations and developments in surgical coloproctologyRisk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancersGenotypic characteristics of resistant tumors to pre-operative ionizing radiation in rectal cancerCurrent approaches and challenges for monitoring treatment response in colon and rectal cancerRectal cancer: An evidence-based update for primary care providersCurrent debate in the oncologic management of rectal cancer.Imaging Advances in Colorectal CancerWait-and-see treatment strategies for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysisCombination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy.Chemoradiation as definitive treatment for primary squamous cell cancer of the rectum.Modern management of rectal cancer: a 2006 update.Locally advanced rectal cancer: does assessment of response after neoadjuvant chemoradiotherapy impact management?HDAC inhibitor, valproic acid, induces p53-dependent radiosensitization of colon cancer cells.Multidisciplinary treatment of rectal cancer in 2014: where are we going?The CARTS study: Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery.Overview of radiation therapy for treating rectal cancer.Clinical significance of tumor regression grade in rectal cancer with preoperative chemoradiotherapyImproving chemoradiotherapy with nanoparticle therapeutics.Sphincter preservation for distal rectal cancer--a goal worth achieving at all costs?The effect of neoadjuvant chemoradiotherapy on whole-body physical fitness and skeletal muscle mitochondrial oxidative phosphorylation in vivo in locally advanced rectal cancer patients--an observational pilot studyLocally advanced rectal cancer: the importance of a multidisciplinary approach.Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patientsLocal excision after preoperative chemoradiation results in an equivalent outcome to total mesorectal excision in selected patients with T3 rectal cancer.Diffusion-weighted magnetic resonance application in response prediction before, during, and after neoadjuvant radiochemotherapy in primary rectal cancer carcinoma.A multicentric randomized controlled trial on the impact of lengthening the interval between neoadjuvant radiochemotherapy and surgery on complete pathological response in rectal cancer (GRECCAR-6 trial): rationale and design.Molecular diagnosis of response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer.Predicting complete response: is there a role for non-operative management of rectal cancer?Management of oligometastatic rectal cancer: is liver first?Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinomaOrgan preservation in rectal cancer patients following complete clinical response to neoadjuvant chemoradiotherapy: Long-term results in three patientsIdentification of a biomarker profile associated with resistance to neoadjuvant chemoradiation therapy in rectal cancerLong-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategiesPredicting tumor response after preoperative chemoradiation using clinical parameters in rectal cancer.Tumor Volume Reduction Rate Predicts Pathologic Tumor Response of Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemotherapy alone: Results from a Prospective TrialLow rectal cancer: Sphincter preserving techniques-selection of patients, techniques and outcomesMRI Risk Stratification for Tumor Relapse in Rectal Cancer Achieving Pathological Complete Remission after Neoadjuvant Chemoradiation Therapy and Curative Resection.Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.
P2860
Q26738806-8D2B9007-6730-4DAA-8F19-55044A619886Q26781457-BFEDDA33-548B-4AD0-865D-BE96A7089062Q26796352-82E24521-928A-4F68-BC42-64C6ABA1EA87Q26822454-1C9B668C-76D4-4224-8850-F1EE117E21E9Q26853016-5556ADB8-E6D1-4838-833D-2BBD21C876ACQ27007505-BA1B27ED-3938-461C-B03C-D9CB018C40F9Q27010257-A3BD5870-5A21-4E27-89C2-104F79209320Q27013068-BEE6C4DC-BAA6-4B08-B218-174E72B056CBQ28072948-AA23DC1E-6BAF-4B41-9C69-441E703D38C1Q28075896-FEAC452B-5193-400B-A273-37B8ECC94DEDQ28078809-80497834-2CF8-4649-88DE-F191B207842BQ31095551-6128332E-D307-40FB-8147-3709EC51E0E6Q33772521-A94146AB-C011-442E-9FC8-0E1DCF66A78DQ33868392-D70D4FEE-9600-4765-9A32-DC82E63BC0F5Q33886095-7DC728A2-D4CF-45E7-B673-CA0AC1265A25Q34062580-31D0FBC7-3A51-45D4-BCDA-7241D05896B1Q34093825-3828DF99-EE9A-4C5B-B0B9-4DFB8C065EFEQ34101866-BE96C73E-80E1-4115-809F-C1E233BF1C60Q34136267-75EEDF56-11EE-4FE3-A260-C9DEAD2D4CF7Q34385284-45AF8ABB-BAFD-4474-920B-1A99944774B5Q34564219-DBF8D649-1B7C-4739-9CDD-B6D36E2C257BQ34635027-C8E08209-77E7-429F-9453-65A164A65147Q34639381-64EB3680-C44E-4ADA-AFB1-33435FDCD00EQ34696515-9E50134C-1D02-4A8B-9413-41C88ED75270Q34787505-D44E90ED-3908-4EAD-BF31-C01D557E4C8DQ34791991-EAB36737-4ED0-495C-AF27-B53B5E567BD0Q34927668-73806968-65D7-4BD8-850B-50ACA13A59C5Q34985904-F15FAD48-C682-4F2E-A745-903DCB7F9328Q35013576-8802437F-C827-4546-BBB2-C64B7F47EFDDQ35029046-893566DC-FD21-4EDE-99B6-140B98324671Q35029056-04BE6C28-8282-4768-8E53-D11DFD48F0B6Q35034753-1977DFB7-C553-47CD-915E-93C76ABDDB95Q35233370-F03C99AC-1343-41F9-9528-FF3821C57FAAQ35460703-C8E16B49-3C9A-4AD3-B990-67914D5502DFQ35569457-3AB5801B-A46E-4243-B4BC-C79F47E970BBQ35638806-D6FACC5E-1249-418A-922F-9E23AF158A6EQ35739533-8EB18C7C-9AF4-47DF-AF02-E9F6B67991D4Q35850663-C055F4B8-CDCF-496C-8A6A-BE595B76BC9DQ35885124-0C7CADA8-7E75-4E9F-A771-65F43B2218F8Q35920508-7114E040-C3AD-453C-BF3E-2C9F5D1F14EE
P2860
Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Operative versus nonoperative ...... on therapy: long-term results.
@en
Operative versus nonoperative ...... on therapy: long-term results.
@nl
type
label
Operative versus nonoperative ...... on therapy: long-term results.
@en
Operative versus nonoperative ...... on therapy: long-term results.
@nl
prefLabel
Operative versus nonoperative ...... on therapy: long-term results.
@en
Operative versus nonoperative ...... on therapy: long-term results.
@nl
P2093
P2860
P1433
P1476
Operative versus nonoperative ...... ion therapy: long-term results
@en
P2093
Afonso Henrique Silva e Sousa
Angelita Habr-Gama
Desidério Roberto Kiss
Fábio Guilherme Campos
Joaquim Gama-Rodrigues
Jorge Sabbaga
Rodrigo Oliva Perez
Wladimir Nadalin
P2860
P304
711-7; discussion 717-8
P356
10.1097/01.SLA.0000141194.27992.32
P407
P577
2004-10-01T00:00:00Z